Trials / Sponsors / Vincerx Pharma, Inc.
Vincerx Pharma, Inc.
Industry · 4 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Study of VIP943 in Subjects With Advanced CD123+ Hematologic Malignancies Acute Myeloid Leukemia, B-cell Acute Lymphoblastic Leukemia, High-risk Myelodysplastic Syndrome | Phase 1 | 2023-09-13 |
| Completed | Phase 1 Dose Escalation Study for VIP236 in Patients With Advanced Cancer Neoplasms | Phase 1 | 2023-01-24 |
| Terminated | A Study to Evaluate VIP152 in Subjects With Relapsed/Refractory Chronic Lymphocytic Leukemia or Richter Syndro Relapsed Non Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, Refractory Chronic Lymphocytic Leukemia | Phase 1 | 2021-12-16 |
| Completed | Phase I Dose Escalation Study for VIP152 in Patients With Advanced Cancer Neoplasms | Phase 1 | 2016-02-10 |